SUVEN PHARMACEUTICALS
|
SUVEN PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹406 Cr | ₹560 Cr | ₹668 Cr | ₹468 Cr | ₹405 Cr |
Adjustment | ₹15 Cr | ₹37 Cr | ₹41 Cr | ₹36 Cr | ₹35 Cr |
Changes In working Capital | ₹47 Cr | ₹5.77 Cr | ₹-194 Cr | ₹-12 Cr | ₹54 Cr |
Cash Flow after changes in Working Capital | ₹468 Cr | ₹603 Cr | ₹514 Cr | ₹492 Cr | ₹493 Cr |
Cash Flow from Operating Activities | ₹358 Cr | ₹457 Cr | ₹330 Cr | ₹383 Cr | ₹407 Cr |
Cash Flow from Investing Activities | ₹-362 Cr | ₹-195 Cr | ₹-136 Cr | ₹-311 Cr | ₹-413 Cr |
Cash Flow from Financing Activities | ₹-14 Cr | ₹-242 Cr | ₹-156 Cr | ₹-76 Cr | ₹7.32 Cr |
Net Cash Inflow / Outflow | ₹-18 Cr | ₹20 Cr | ₹37 Cr | ₹-4.51 Cr | ₹0.79 Cr |
Opening Cash & Cash Equivalents | ₹65 Cr | ₹45 Cr | ₹7.18 Cr | ₹12 Cr | ₹11 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | ₹0.00 Cr | - | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
Closing Cash & Cash Equivalent | ₹47 Cr | ₹65 Cr | ₹45 Cr | ₹7.18 Cr | ₹12 Cr |
Compare Cashflow Statement of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,771.1 Cr | 7.1% | 2.5% | 74.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,699.0 Cr | 0.6% | -4.6% | 20.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,584.0 Cr | 9.8% | 4.5% | 64.7% | Stock Analytics | |
CIPLA | ₹116,022.0 Cr | -2.9% | -3.9% | 1.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,463.0 Cr | 0.9% | -10.4% | 0.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,434.8 Cr | 0.9% | -0.3% | 27.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | 7.1% |
2.5% |
74.1% |
SENSEX | 2% |
0.1% |
8.6% |
You may also like the below Video Courses